ArticleObesity pillars2026

Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion.

Michael Kyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.